Riskpilot← Back to searchSign inGet full accessVITO MEDICAL AS
ASActiveOrg 925178039Sparavollen 79, 3021 DrammenEngineering activities and related technical consultancy · NACE 7112Est. 20200 employees
Revenue 2025
NOK 1,9M
+55% vs 2024
EBITDA margin
-8.9%
+57% vs 2024
Equity ratio
98.0%
Financial strength
Net profit 2025
NOK -167K
-46% vs 2024
| Revenue | NOK 1,9M | +55% |
| EBITDA | NOK -166K | +57% |
| Net profit | NOK -167K | -46% |
| Total assets | NOK 4,3M | -7% |
| Equity | NOK 4,2M | -4% |
| Employees | 0 | — |
Legal name
VITO MEDICAL AS
Org number
925178039
Legal form
Aksjeselskap
NACE code
7112 · Engineering activities and related technical consultancy
Founded
10. juni 2020
Share capital
NOK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Å drive utvikling, design, salg, rådgivning innen segmentet medisinsk utstyr og helseprodukter til sykehus, pleiehjem, bedrifter og andre institusjoner og alt som står i forbindelse meg dette. Videre delta i andre virksomheter med tilsvarende formål.
Address
Sparavollen 79, 3021 Drammen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 6 136 | 597 | 14 | 1 202 | 1 868 |
| Staff expenses | −1 682 | −542 | 43 | −25 | −6 |
| EBITDA | −949 | −535 | −237 | −381 | −166 |
| Depreciation & amort. | −25 | −27 | −27 | −27 | −27 |
| EBIT | −974 | −562 | −264 | −408 | −193 |
| Net financials | −17 | 59 | 286 | 294 | 25 |
| Profit before tax | −990 | −503 | 21 | −114 | −167 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −990 | −503 | 21 | −114 | −167 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 15 225 | 4 538 | 4 492 | 4 608 | 4 276 |
| Equity | 14 885 | 4 452 | 4 473 | 4 359 | 4 192 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 340 | 86 | 19 | 249 | 84 |
| Total debt | 340 | 86 | 19 | 249 | 84 |
EBITDA margin
-8.9%
This company
15.8%
Market median
-156% vs market
20212025
Equity ratio
98.0%
This company
38.2%
Market median
+157% vs market
20212025
Return on equity
-4.0%
This company
18.4%
Market median
-122% vs market
20212025
Net profit margin
-9.0%
This company
8.1%
Market median
-211% vs market
20212025
Asset turnover
0.44×
This company
1.12×
Market median
-61% vs market
20212025
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MF Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2020 | |
| Board of Directors | 2020 | |
| Chairman | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50% | 50% | 2022 | |
| Company | 50% | 50% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Hattfjell Consulting As
VITO MEDICAL AS Board members of VITO MEDICAL AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Morten Forrestad Winness | Chief Executive Officer | 0 companies |
| Marion Evy Kristoffersen | Board of Directors | 0 companies |
| Eli Helene Køste Winness | Board of Directors | 0 companies |
| Jan Kristian Furuseth | Chairman | 0 companies |